# Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis

> **NCT07706270** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 138 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)
- Neurodegenerative Disorders
- Motor Neuron Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Serum Neurofilament Serum NfL Measurement

## Key facts

- **NCT ID:** NCT07706270
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706270, "Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*